Position in CELC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$114,140
+$96,140 QoQ
Shares Held
1,000
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026HARBOUR INVESTMENTS, INC. holds $3,336,084 across 121 Biotechnology names. CELC ranks #7 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VKTX |
Viking Therapeutics, Inc.
|
17,230 | $560,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
640 | $494,489 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
888 | $396,527 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,384 | $261,645 | |
| 5 | OMER |
Omeros Corp
|
22,025 | $232,584 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
3,489 | $165,971 | |
| 7 | CELC |
Celcuity Inc.
This page
|
1,000 | $114,140 | |
| 8 | STOK |
Stoke Therapeutics, Inc.
|
3,352 | $109,141 |
All Filings in CELC
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $114,140 | 1,000 | Shares | Sole | 2026-05-15 | |
| 2021-09-30 | $18,000 | 1,000 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $24,000 | 1,000 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $14,340 | 1,000 | Shares | Sole | 2021-08-17 | |
| No filing history on record for this holder in this stock. | ||||||